Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
CAH 
Cardinal Health Inc (CAH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: CAH (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
AI Based Fundamental Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Analysis of Past Performance
Type Stock | Historic Profit 39.81% | Avg. Invested days 42 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 33.28B USD | Price to earnings Ratio 25.66 | 1Y Target Price 141.87 |
Price to earnings Ratio 25.66 | 1Y Target Price 141.87 | ||
Volume (30-day avg) 2480726 | Beta 0.68 | 52 Weeks Range 92.01 - 138.11 | Updated Date 03/31/2025 |
52 Weeks Range 92.01 - 138.11 | Updated Date 03/31/2025 | ||
Dividends yield (FY) 1.47% | Basic EPS (TTM) 5.37 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.59% | Operating Margin (TTM) 1.02% |
Management Effectiveness
Return on Assets (TTM) 3.01% | Return on Equity (TTM) - |
Valuation
Trailing PE 25.66 | Forward PE 15.15 | Enterprise Value 36755536964 | Price to Sales(TTM) 0.15 |
Enterprise Value 36755536964 | Price to Sales(TTM) 0.15 | ||
Enterprise Value to Revenue 0.17 | Enterprise Value to EBITDA 14 | Shares Outstanding 241568000 | Shares Floating 240265942 |
Shares Outstanding 241568000 | Shares Floating 240265942 | ||
Percent Insiders 0.25 | Percent Institutions 89.15 |
Analyst Ratings
Rating 4 | Target Price 132.14 | Buy 2 | Strong Buy 8 |
Buy 2 | Strong Buy 8 | ||
Hold 6 | Sell 1 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Cardinal Health Inc
Company Overview
History and Background
Cardinal Health was founded in 1971 as Cardinal Foods, a food wholesaler. In the 1980s, it transitioned to pharmaceutical distribution through acquisitions. Over the years, it expanded into medical products and services, becoming a major player in healthcare supply chain solutions.
Core Business Areas
- Pharmaceutical Distribution: Distributes branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare products to pharmacies, hospitals, and healthcare providers.
- Medical Segment: Manufactures, sources, and distributes medical, surgical, and laboratory products, and provides related services to hospitals, surgery centers, and other healthcare facilities.
Leadership and Structure
The CEO is Jason Hollar. The company operates with a divisional structure aligned with its pharmaceutical and medical segments, overseen by senior leadership with expertise in supply chain, healthcare, and finance.
Top Products and Market Share
Key Offerings
- Pharmaceutical Distribution Services: Distribution of generic and branded pharmaceuticals, representing a significant portion of their revenue. Major competitors include McKesson (MCK) and AmerisourceBergen (ABC). Cardinal Health's overall market share within the pharmaceutical distribution industry is substantial, though specific figures fluctuate.
- Medical Products and Services: Includes medical supplies, surgical products, and patient care items. Competitors include Medline Industries and Owens & Minor (OMI). Revenue from this segment also comprises a substantial amount.
Market Dynamics
Industry Overview
The healthcare supply chain industry is characterized by high volume, low margins, and increasing consolidation. Regulatory pressures, pricing dynamics, and technological advancements are key drivers.
Positioning
Cardinal Health is one of the top three pharmaceutical distributors in the US, with a strong position in medical products. It leverages its scale, distribution network, and customer relationships to maintain a competitive edge.
Total Addressable Market (TAM)
The total addressable market for pharmaceutical distribution and medical supplies is estimated to be in the hundreds of billions of dollars annually. Cardinal Health captures a significant portion of this TAM through its extensive distribution network and product offerings.
Upturn SWOT Analysis
Strengths
- Large-scale distribution network
- Strong relationships with pharmacies and hospitals
- Diverse product portfolio
- Established brand reputation
- Significant market share in pharmaceutical distribution
Weaknesses
- Low profit margins in pharmaceutical distribution
- Exposure to generic drug pricing pressures
- Dependence on key suppliers
- Potential for regulatory scrutiny
- Debt level
Opportunities
- Expanding into specialty pharmaceuticals
- Leveraging technology to improve supply chain efficiency
- Acquiring smaller competitors
- Growth in home healthcare market
- Expansion of medical segment
Threats
- Increasing competition from other distributors
- Pricing pressures from drug manufacturers and payers
- Regulatory changes impacting drug distribution
- Economic downturn affecting healthcare spending
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- MCK
- ABC
- OMI
Competitive Landscape
Cardinal Health's advantages include its scale, established customer relationships, and diverse product portfolio. Disadvantages include low profit margins and exposure to pricing pressures. McKesson and AmerisourceBergen are its primary competitors.
Major Acquisitions
Patient Recovery
- Year: 2022
- Acquisition Price (USD millions): 534
- Strategic Rationale: Expanded their at-home solutions offerings and enhanced post-acute care capabilities.
Growth Trajectory and Initiatives
Historical Growth: Cardinal Health's growth has been driven by acquisitions and organic expansion in its pharmaceutical and medical segments.
Future Projections: Analyst estimates vary, but projections generally anticipate moderate revenue growth and earnings improvement due to cost optimization and market expansion.
Recent Initiatives: Recent initiatives include investments in supply chain technology, expansion of its specialty pharmaceutical offerings, and strategic acquisitions.
Summary
Cardinal Health is a large and established healthcare distributor with a significant market share, particularly in pharmaceuticals. Its strengths lie in its scale, distribution network, and customer relationships. However, low margins and pricing pressures pose challenges. Strategic initiatives to diversify and improve efficiency are crucial for sustained growth.
Similar Companies
- MCK
- ABC
- CVS
- WBA
- AMZN
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Analyst Reports
- Industry Publications
- Company Website
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute financial advice. Market share data are estimates and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cardinal Health Inc
Exchange NYSE | Headquaters Dublin, OH, United States | ||
IPO Launch date 1987-12-31 | CEO & Director Mr. Jason M. Hollar | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 47922 | Website https://www.cardinalhealth.com |
Full time employees 47922 | Website https://www.cardinalhealth.com | ||
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.